BRAD LEWIS: Open Payments
NPI 1730315748 · CRESSON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 69 payments from 12 companies in 2025. Trend: 2023 $1,168 · 2024 $1,158 · 2025 $1,080
Food & beverage: $1,080
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 38 | $458 |
| PFIZER INC. | 9 | $151 |
| TOLMAR, INC. | 4 | $92 |
| ABBVIE INC. | 4 | $85 |
| Verity Pharmaceuticals Inc. | 3 | $60 |
| Boston Scientific Corporation | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $22 |
Products named: GEMTESA, ORGOVYX, XTANDI, JATENZO, LUPRON DEPOT, ERLEADA, Nubeqa, Trelstar.
Industry payments across PA — which companies pay providers there.
